Proinflammatory cytokines: a pathogenic key in POEMS syndrome;LES CYTOKINES PRO-INFLAMMATOIRES: UNE CLE PATHOGENIQUE DU SYNDROME POEMS

Revue Neurologique

Volumn 152, Issue 5, 1996, Pages 409-412

  Gherardi, R K ^a   Authier, F J ^a   Belec, L ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; HUMAN; INFLAMMATION; MYELOMA; POLYNEUROPATHY;

CYTOKINES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; MONOKINES; MULTIPLE MYELOMA; PEPTIDE FRAGMENTS; POEMS SYNDROME; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029683317     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. BELEC L., MEILLET D., GHERARDI R. (1995). Increased tumor necrosis factor-α serum levels in patients with AIDS and euthyroid sick syndrome. J Acqu Immune Defic Syndr Hum Retrovirol, 8 : 212-215.
2. CRÉANGE A., BELEC L., CLAIR B., RAPHAËL J.C., GHERARDI R.K. (1995). Differential kinetics of circulating tumor necrosis factor (TNF)-alpha and soluble TNF receptors (sRNFrs) in patients with Guillain-Barré syndrome (GBS). Neurology, 45 (suppl 4) : A415-416.
3. DINARELLO C.A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood. 77 : 1627-52.
4. FUKATSU A., ITO Y., YUZAWA Y., KATO M., MIYAKAWA K., MATSUO S. (1992). A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron, 62 : 47-51.
5. GHERARDI R., ZUBER M., VIARD J.P. (1988a). Les neuropathies dysglobulinémiques. Rev Neurol (Paris), 144 : 391-408.
6. GHERARDI R., BAUDRIMONT M., KUJAS M., MALAPERT D., LANGE F., GRAY F., POIRIER J. (1988b). Pathological findings in three non-japanese patients with the POEMS syndrome. Virchows Arch (A), 413 : 357-365.
7. GHEARDI R.K., CHOUAÏB S., MALAPERT D., BELEC L., INTRATOR L., DEGOS J.D. (1994a). Early weight loss and high serum levels of tumor necrosis factor-α in POEMS syndrome. Ann Neurol, 35 : 501-5.
8. GHERARDI R.K., BELEC L., FROMONT G., DIVINE M., MALAPERT D., GAULARD P., DEGOS J.D. (1994b). Elevated levels of IL-1ß and IL-6 in serum, and increased production of IL-1ß mRNA in lymph nodes of patients with POEMS syndrome. Blood, 83 : 2587-2593.
9. GHERARDI R.K., BELEC L., AUTHIER F.J., DEGOS J.D. (1995). Cytokines and cytokine antagonists in POEMS syndrome. Neurology. 45 (suppl 4) : A237.
10. GHERARDI R.K., BELEC L., SOUBRIER M., MALAPERT D., ZUBER M., VIARD J.P., INTRATOR L., DEGOS J.D., AUTHIER F.J. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood (sous presse).
11. HSU S.M., WALDRON J.A., XIE S.S., BARLOGIE B. (1993). Expression of interleukin-6 in Castleman's disease. Hum Pathol, 24 : 833-6.
12. KISHIMOTO T. (1989). The biology of interleukin-6. Blood, 74 : 1-10.
13. KOILE K., MASUMOTO N., KASAHARA K., YAMAGUCHI M., TASAKA K., HIROTA K., MIYAKE A., TANIZAWA O. (1991). Tumor necrosis factor-α stimulates prolactin release from anterior pituitary cells : a possible involvement of intracellular calcium mobilization. Endocrinology, 128 : 2785-90.
14. LEGER-RAVET M.B., PEUCHMAUR M., DEVERGNE O., AUDOIN J., RAPHAEL M., VAN DAMME J., GALANAUD P., DIEBOLD J., EMILIE D. (1991). Interleukin-6 gene expression in Castleman's disease. Blood, 78 : 2923-30.
15. MANDLER R.N., KERRIGAN D.P., SMART J., KUIS W., VILLIGER P., LOTZ. M. (1992). Castleman's disease in POEMS syndrome with elevated interleulin-6. Cancer, 69 : 2697-703.
16. MEALY K., ROBINSON B., MILLETTE C.F., MAJZOUB J., WILMORE D.W. (1990). The testicular effects of tumor necrosis factor. Ann Surg, 211 : 470-5.
17. MIRALLES G.D., O'FALLON J.R., TALLEY N.J. (1992). Plasma cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med, 327 : 1919-23.
18. NAKANISHI T., SOBUE I., TOYOKURA Y., NISHITANI H., KUROIWA Y , SATOYOSHI E., TSUBAKI T., IGATA A., OZAKI Y. (1984). The Crow-Fukase syndrome : a study of 102 cases in Japan. Neurology, 34 : 712-720.
19. PANG X.P., HERSHMAN J.M., MIRELL C.J., PEKARY A.E. (1989). Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-α (cachectin). Endocrinology, 125 : 76-84.
20. PATTON J.S., PETERS P.M., MCCABE J., CRASE D., HANSEN S., CHEN A.B., LIGGITT D. (1987). Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-α in rodents. J Clin Invest. 80 : 1587-96.
21. REDFORD E.J., HALL S.M., SMITH K.J. (1995). Vascular changes and demyelination induced by the intraneural injection of tumour factor. Brain, 118 : 869-78.
22. REULECKE M., DUMAS M., MEIER C. (1988). Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology, 38 : 614-616.
23. SELMAJ K., RAINE C.S., CROSS H.H. (1991). Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol, 30 : 694-700.
24. SHARIEF M.K., MCLEAN B., THOMSON E.J. (1993). Elevated serum levels of tumor necrosis factor-α in Guillain-Barré syndrome. Ann Neurol, 33 : 591-6.
25. TRACEY K.J., CERAMI A. (1992). Pleiotropic effects of TNF in infection and neoplasia : beneficial, inflammatory, catabolic, or injurious. Immunol Ser, 56 : 431-4.
26. TRACEY K.J., MORGELLO S., KOPLIN B., FAHEY T.J., Fox J., ALEDO A., MANOGUE K.R., CERAMI A. (1990). Metabolic effects of cachectin/tumor necrosis factor are modified by the site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominately acute anorexia. J Clin Invest, 86 : 2014-24.
27. TSUNAWAKI S., SPORN M., DING A., NATHAN C. (1988). Deactivation of macrophages by transforming growth factor-ß. Nature, 334 : 260-62.
28. YOSHIZAKI K., MATSUDA T., NISHIMOTO N., KURITANI T., TAEHO L., AOSAKA K. , NAKAHATA T., KAWAI H. (1989). Pathogenic significance of interleulin-6 (IL-6/BSF-2) in Castleman's disease. Blood, 74 : 1360-7.